Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
Saved in:
| Title: | Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment. |
|---|---|
| Authors: | Mogalian E; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA. Erik.Mogalian@gilead.com., Brainard DM; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA., Osinusi A; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA., Moorehead L; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA., Murray B; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA., Ling KHJ; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA., Perry R; Elite Research Institute, Miami, FL, USA., Curtis C; Compass Research, Orlando, FL, USA., Lawitz E; Texas Liver Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Lasseter K; Clinical Pharmacology of Miami, Miami, FL, USA., Marbury T; Orlando Clinical Research Center, Orlando, FL, USA., Mathias A; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2018 Nov; Vol. 57 (11), pp. 1449-1457. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1926 |
|---|---|
| DOI: | 10.1007/s40262-018-0645-6 |
